Immune suppression of anti-DNA antibody production using anti-idiotypic antibody-neocarzinostatin conjugates.
Sasaki
T
T
Koide
Y
Y
Yoshigaga
K
K
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000888:Antibodies, Anti-Idiotypic / Q000302:isolation & purification; D000911:Antibodies, Monoclonal; D000917:Antibody Formation / Q000187:drug effects*; D002478:Cells, Cultured; D004247:DNA / Q000276:immunology*; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins; D005456:Fluorescent Dyes; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000032:analysis; D007165:Immunosuppression Therapy; D007202:Indicators and Reagents; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013050:Spectrometry, Fluorescence / Q000379:methods; D013861:Thiocyanates; D009353:Zinostatin / Q000276:immunology / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007130:Immunoglobulin Idiotypes; D007202:Indicators and Reagents; D013861:Thiocyanates; D004247:DNA; D009353:Zinostatin; D016650:Fluorescein-5-isothiocyanate